Bummer! Sales have ended.
Unfortunately, tickets for this event are no longer on sale.
Enabling price reductions through generic competition is the most sustainable mechanism to ensure affordable access to ARV, but generic competition is threatened by new intellectual property (IP) barriers that extend pharmaceutical monopolies and keep drug prices high. Safeguards available in international law and used to mitigate IP barriers when public health needs exist are increasingly important.
Drawing on new tools and case studies from South Africa, Brazil, Argentina and India, this workshop will empower participants to identify IP barriers, assess impact on specific medical products, and design campaigns to implement legal and policy actions, including compulsory licenses, patent oppositions, and stricter patentability requirements.
Participants will also learn how to use various practical tools, including a new patent opposition database and patent and pricing search tools including UNDP’s patent methodology and MSF’s Untangling the Web of Antiretroviral Price Reductions.
Judit Rius Sanjuan
Felipe de Carvalho
María Lorena Di Giano